Back to search
Ankylosing Spondylitis (AS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ankylosing Spondylitis (AS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ankylosing Spondylitis (AS) trials you may qualify forThis study is a multicenter, prospective cohort study designed to systematically evaluate the clinical efficacy of integrated Traditional Chinese and Western Me…
Rheumatic diseases constitute a group of non-communicable diseases characterized by chronic inflammation. The most common autoimmune rheumatic diseases (ARDs) a…
An observational, ambispective cohort to learn about the disease progression of axial spondyloarthritis (axSpA) according to the changes from baseline in measur…
This study is a multicentre, ambidirectional, observational cohort study. The ambidirectional design incorporates both the collection of retrospective data from…
Exercise may be considered the gold standard for the management of mechanical and functional symptoms associated with patients having AS and they are considered…
This is an observational study to evaluate the effectiveness and safety of secukinumab in participants with AS who have never used TNFi, JAKi, or IL-17i drugs b…
The purpose of the study is to demonstrate the long-term safety, tolerability and efficacy of bimekizumab in patients with active axial spondyloarthritis (axSpA…
the main objectives are 1. to study the pathophysiological role of KIR3DL2 in axSpA and its relationship with Th17 immunity in HLA-B27 + and HLA-B27- patients…